ADVASA has raised no outside funding. Healthcare services. The last valuation is $2.5B, dated Apr 2022.
Advasa Holdings, the US parent of ADVASA Co., Ltd., completed a direct listing on the Nasdaq Global Market in August 2026 under the ticker ADBT. Its Form S-1 registration statement was declared effective by the SEC on August 11, 2026, and the company has not disclosed a venture funding round.
ADVASA was founded in 2017, Japan.
Healthcare services. The company is valued at $2.5B , dated Apr 2022.
No filing has been made.
Healthcare services.
Last valuation$2.5BApr 2022
Lightspeed Venture PartnersThe routes section explains what is realistically available for a company at this stage.
No. ADVASA is a private company; its shares do not trade on a public exchange.
The last valuation is $2.5B.
Lead investors for each round are in the funding timeline.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
